お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
963627

医療シミュレーションの世界市場:製品/サービス別、忠実度別、エンドユーザー別の機会分析と業界予測、2020年~2027年

Medical Simulation Market by Product & Services, Fidelity, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 196 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.61円
医療シミュレーションの世界市場:製品/サービス別、忠実度別、エンドユーザー別の機会分析と業界予測、2020年~2027年
出版日: 2020年08月31日
発行: Allied Market Research
ページ情報: 英文 196 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療シミュレーション市場は、2019年の14億2,110万米ドルから2027年には31億9,020万米ドルに拡大すると予測されており、2020年から2027年までのCAGRは14.6%になる見通しです。

医療シミュレーションは、医療現場での活動や現象をバーチャルな空間に複製したもので、高度な医療技術を使用する医療従事者を訓練するために用いられます。市場拡大の原動力となるのは、医療過誤による死亡の増加、患者の安全性を改善する必要性、複雑な症例や通常の症例のトレーニング、医療分野での技術の進歩などの要因です。

また、新型コロナウイルス感染症(COVID-19)のパンデミックが世界各国の医学教育に及ぼしている前例のない影響も市場拡大の追い風となります。パンデミックに伴って講義や試験、臨床研修が困難になるなか、医療シミュレーションは臨床研修の代替的な手段として注目を集めています。

当レポートは、世界の医療シミュレーション市場を調査したもので、市場の概要、製品/サービス別、忠実度別、エンドユーザー別、地域別の分析、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 市場を形成する主な力
  • 市場シェア分析
  • 市場の力学
    • 促進要因
      • バーチャルリアリティと拡張現実の利用拡大
      • 患者の安全性の確実な改善
      • 医療シミュレーションの利点
      • 医療分野における技術の進歩
      • 仮想トレーニングの需要拡大
    • 抑制要因
      • シミュレーターのセットアップに必要な多額の費用
      • 現実の状況を完全に再現するうえでの制約
    • 市場機会
      • 新興市場での機会
  • COVID-19が市場に与える影響

第4章 市場分析:製品/サービス別

  • 概要
  • 市場規模と予測
    • モデルベースのシミュレーション
      • 患者シミュレーション
      • 外科シミュレーション
      • 超音波シミュレーション
    • Webベースのシミュレーション
    • シミュレーショントレーニングサービス

第5章 市場分析:忠実度別

  • 概要
  • 市場規模と予測
    • 高忠実度
    • 中忠実度
    • 低忠実度

第6章 市場分析:エンドユーザー別

  • 概要
  • 市場規模と予測
    • 学術機関
    • 病院
    • 軍事組織

第7章 市場分析:地域別

  • 市場規模と予測
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他
  • ラテンアメリカ、中東、アフリカ
    • ブラジル
    • 南アフリカ
    • サウジアラビア
    • その他

第8章 企業プロファイル

  • 3D SYSTEMS CORPORATION (SIMBIONIX)
  • CAE INC.
  • GAUMARD SCIENTIFIC COMPANY
  • KYOTO KAGAKU CO. LTD.
  • LAERDAL MEDICAL AS
  • LIMBS AND THINGS LTD.
  • MENTICE AB
  • SIMULAB CORPORATION
  • SIMULAIDS INC.
  • SURGICAL SCIENCE SWEDEN AB
図表

LIST OF TABLES

  • TABLE 01.GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES, 2019-2027 ($MILLION)
  • TABLE 02.GLOBAL MODEL-BASED SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 03.GLOBAL PATIENT SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 04.GLOBAL SURGICAL SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 05.GLOBAL WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 06.GLOBAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 07.GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 08.GLOBAL MEDICAL SIMULATION MARKET FOR HIGH FIDELITY, BY REGION, 2019-2027($MILLION)
  • TABLE 09.GLOBAL MEDICAL SIMULATION MARKET FOR MEDIUM-FIDELITY, BY REGION, 2019-2027($MILLION)
  • TABLE 10.GLOBAL MEDICAL SIMULATION MARKET FOR LOW-FIDELITY, BY REGION, 2019-2027($MILLION)
  • TABLE 11.GLOBAL MEDICAL SIMULATION MARKET, BY END USER 2019-2027 ($MILLION)
  • TABLE 12.GLOBAL MEDICAL SIMULATION MARKET FOR ACADEMCI INSTITUTIONS, BY REGION, 2019-2027($MILLION)
  • TABLE 13.GLOBAL MEDICAL SIMULATION MARKET FOR HOSPITALS, BY REGION, 2019-2027($MILLION)
  • TABLE 14.GLOBAL MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY REGION, 2019-2027($MILLION)
  • TABLE 15.MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.NORTH AMERICA MEDICAL SIMULATION MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 17.U.S. MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 18.U.S. MODEL-BASED SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 19.U.S. PATIENT SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 20.U.S. PATIENT SIMULATION MARKET, BY PATIENT TYPE, 2019-2027 ($MILLION)
  • TABLE 21.U.S. SURGICAL SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 22.U.S. ULTRASOUND SIMULATION MARKET, BY TYPE, 2019-2027($MILLION)
  • TABLE 23.U.S. WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 24.U.S. SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 25.U.S. MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 26.U.S. MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 27.CANADA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 28.CANADA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 29.CANADA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 30.MEXICO MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 31.MEXICO MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 33.NORTH AMERICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 34.NORTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 35.NORTH AMERICA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 36.EUROPE MEDICAL SIMULATION MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 37.GERMANY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 38.GERMANY MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 39.GERMANY MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 40.FRANCE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 41.FRANCE MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 42.FRANCE MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 43.UK MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 44.UK MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 45.UK MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 46.ITALY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 47.ITALY MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 48.ITALY MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 49.SPAIN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 50.SPAIN MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 51.SPAIN MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 52.REST OF EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 53.REST OF EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 54.REST OF EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 55.EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 56.EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 57.EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 58.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 59.JAPAN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 60.JAPAN MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 61.JAPAN MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 62.CHINA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 63.CHINA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 64.CHINA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 65.INDIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 66.INDIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 67.INDIA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 68.AUSTRALIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 69.AUSTRALIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 70.AUSTRALIA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 71.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 72.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 73.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 74.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 75.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 76.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 77.LAMEA MEDICAL SIMULATION MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 78.BRAZIL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 79.BRAZIL MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 80.BRAZIL MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 81.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 82.SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 83.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 84.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 85.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 86.SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2019-2027 ($MILLION)
  • TABLE 87.REST OF LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 88.REST OF LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 89.REST OF LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 90.LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019-2027 ($MILLION)
  • TABLE 91.LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019-2027 ($MILLION)
  • TABLE 92.LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 93.3D SYSTEMS: COMPANY SNAPSHOT
  • TABLE 94.3D SYSTEMS: OPERATING SEGMENTS
  • TABLE 95.3D SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 96.CAE: COMPANY SNAPSHOT
  • TABLE 97.CAE: OPERATING SEGMENTS
  • TABLE 98.CAE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 99.GAUMARD: COMPANY SNAPSHOT
  • TABLE 100.GAUMARD: PRODUCT PORTFOLIO
  • TABLE 101.KYOTO KAGAKU: COMPANY SNAPSHOT
  • TABLE 102.KYOTO KAGAKU: OPERATING SEGMENTS
  • TABLE 103.KYOTO KAGAKU: PRODUCT PORTFOLIO
  • TABLE 104.LAERDAL: COMPANY SNAPSHOT
  • TABLE 105.LAERDAL: OPERATING SEGMENTS
  • TABLE 106.LIMBS & THINGS: COMPANY SNAPSHOT
  • TABLE 107.LIMBS & THINGS: OPERATING SEGMENTS
  • TABLE 108.MENTICE: COMPANY SNAPSHOT
  • TABLE 109.MENTICE: OPERATING SEGMENTS
  • TABLE 110.SIMULAB: COMPANY SNAPSHOT
  • TABLE 111.SIMULAB: OPERATING SEGMENTS
  • TABLE 112.SIMULAIDS: COMPANY SNAPSHOT
  • TABLE 113.SIMULAIDS: OPERATING SEGMENTS
  • TABLE 114.SURGICAL SCIENCE: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01.GLOBAL MEDICAL SIMULATION MARKET SEGMENTATION
  • FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 04.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 05.LOW THREAT OF SUBSTITUTION
  • FIGURE 06.HIGH COMPETITIVE RIVALRY
  • FIGURE 07.MARKET DYNAMICS FOR MEDICAL SIMULATION MARKET
  • FIGURE 08.3D SYSTEMS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 09.3D SYSTEMS: REVENUE SHARE, BY PRODUCT & SERVICES, 2019 (%)
  • FIGURE 10.3D SYSTEMS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 11.CAE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 12.CAE: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 13.CAE: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 14.SURGICAL SCIENCE: NET SALES, 2017-2019 ($MILLION)
目次
Product Code: A02266

Title:
Medical Simulation Market by Product & Services(Model-Based Simulation, Web-Based Simulation, and Simulation Training Services), Fidelity (Low-Fidelity, Medium-Fidelity, and High-Fidelity), and End User (Academic Institutions & Research Centers, Hospitals & Clinics, and Military Organizations): Global Opportunity Analysis and Industry Forecast, 2020-2027 .

The global medical simulation market was valued at $1,421.1 million in 2019, and is projected to reach $3,190.2 million by 2027, growing at a CAGR of 14.6% from 2020 to 2027.

Medical simulation is virtual duplication of in situ activities or phenomenon, representing functions and properties of a selective real abstract or process. It is used to train healthcare professionals using advanced healthcare technologies. The global medical simulation market was valued at $1,412.1 million in 2019, and is estimated to reach $3,190.2 million by 2027, growing at a CAGR of 14.6% from 2020 to 2027.

Rise in use of simulation in healthcare; increase in deaths, owing to medical errors; and necessity to improve patient safety outcomes are some factors that boost the market growth. Moreover, benefits such as training of complex as well as normal cases to professionals and technological advancements in the medical field further increases demand for medical simulation. However, high installation cost and lack of complete real situation restrains the market growth.

Further, COVID-19 has an unprecedented impact on medical education worldwide, leading to cancellation of lectures, exams, clinical rotations, and ultimately temporary closure of medical schools.

In March 2020, the International Nursing Association of Clinical Simulation and Learning (INACSL) and the Society for Simulation in Healthcare (SSH) issued a statement on the 'use of virtual simulation as a replacement for clinical hours' during the pandemic caused by COVID-19. The use of virtual simulation technologies is likely to be adopted during the pandemic to enhance and strengthen procedural and patient care skills. Further, increase in use of remote learning with the help of screen-based simulation, augmented reality/AR, mixed reality, blended and/or extended reality, and virtual reality/VR is expected to drive growth of the virtual medical simulation market.

The global medical simulation market is segmented on the basis of product & service, fidelity, end user, and region. On the basis of product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. The model-based simulation segment is further classified into patient simulation, surgical simulation, and ultrasound simulation. Moreover, patient simulation is segmented into task trainers, manikin-based simulators, and standardized patient simulators. Surgical simulation is divided in laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. In addition, the web-based simulation segment is classified into simulation software, performance-recording software, and virtual tutors. The simulation training services segment comprise vendor-based training services, custom consulting services, and educational society services. By product & service, the model-based segment generated maximum revenue in 2019, accounting $727.47 million in 2019. Web-based simulation segment is expected to witness highest CAGR of 15.2% during the forecast period.

On the basis of fidelity, the market is classified into low-fidelity, medium fidelity, and high-fidelity simulators. By fidelity, the low-fidelity simulators segment dominated the market in 2019 with $671.29 million. High-fidelity segment is expected to witness highest CAGR of 15.3% during the forecast period.

By end user, it is divided into academic institutions & research centers, hospitals & clinics, and military organizations. Based on end user, the hospitals segment dominated the market in 2019 with $761.41. Academic institutions segment is expected to witness highest CAGR of 15.3% during the forecast period.

  • Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest share in the global medical simulation market. Asia-Pacific is expected to witness highest growth rate throughout the forecast period. Increase use of medical simulation to minimize medical errors and further increase technological advancements by companies are anticipated to drive the overall market growth.
  • The major players profiled in the report are Laerdal Medical AS, CAE, Inc., 3D Systems, Inc., Simulab Corporation, Simulaids, Inc., Limbs and Things, Ltd., Kyoto Kagaku Co. Ltd., Mentice AB, Surgical Science Sweden AB, and Gaumard Scientific Company, Inc.
  • KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current medical simulation trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The market forecast is studied from 2020 to 2027.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
  • KEY MARKET SEGMENTS

By Product & Services

  • Model-based Simulation
  • Patient Simulation
  • Task Trainer Simulation
  • Manikin-based Simulation
  • Adult
  • Pediatric
  • Neonatal
  • Hybrid Manikin-based simulation (with AR)
  • Standardized Patient Simulation
  • Surgical Simulation
  • Laparoscopic Surgical Simulators
  • Arthroscopic Surgical Simulators
  • Cardiovascular Simulators
  • Gynecology Simulators
  • Orthopedic Simulators
  • Spine Simulators
  • Endovascular Simulators
  • Others
  • Ultrasound Simulation
  • Anesthesia
  • Cardiology
  • Emergency Medicine
  • Intensive Care Unit
  • OB/GYN
  • Radiology
  • Others (Urology, General Nursing, Pediatrics)
  • Web-based Simulation
  • Simulation Software
  • Performance Recording Software
  • Virtual Tutors
  • Learning Management Software
  • Simulation Training Services
  • Vendor-based Training
  • Custom Consulting Services
  • Educational Societies

By Fidelity

  • Low-fidelity
  • Medium-fidelity
  • High-fidelity

By End User

  • Academic Institutions & Research Centers
  • Hospitals & Clinics
  • Military Organizations

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • KEY MARKET PLAYERS
  • 3D Systems
  • CAE Inc.
  • Gaumard Scientific Company
  • Kyoto Kagaku
  • Laedral Medical
  • Limbs and Things
  • Mentice AB
  • Simulab Corporation
  • Simulaids
  • SurgicalScienceSwede

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key forces shaping the global medical simulation market
  • 3.3.Market share analysis for learning management software
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Increase in use of virtual and augmented reality
      • 3.4.1.2.Assured improvement in patient safety outcomes
      • 3.4.1.3.Benefits of medical simulation
      • 3.4.1.4.Technological advancements in medical field
      • 3.4.1.5.Increase in demand for virtual training
    • 3.4.2.Restraints
      • 3.4.2.1.High cost for setting up simulators
      • 3.4.2.2.Limitation to imitate a complete real situation
    • 3.4.3.Opportunities
      • 3.4.3.1.Lucrative opportunities in emerging markets
  • 3.5.Impact of COVID-19 on Medical Simulation Market

CHAPTER 4:GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Model-based simulation
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by type
      • 4.2.2.1.Patient simulation
      • 4.2.2.1.1.Market size and forecast
      • 4.2.2.2.Surgical simulation
      • 4.2.2.2.1.Market size and forecast
      • 4.2.2.3.Ultrasound simulation
  • 4.3.Web-based simulation
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by type
  • 4.4.Simulation training services
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by type

CHAPTER 5:GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.High-fidelity
    • 5.2.1.Market size and forecast, by region
  • 5.3.Medium-fidelity
    • 5.3.1.Market size and forecast, by region
  • 5.4.Low-fidelity
    • 5.4.1.Market size and forecast, by region

CHAPTER 6:GLOBAL MEDICAL SIMULATION MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Academic institutions
    • 6.2.1.Market size and forecast, by region
  • 6.3.Hospitals
    • 6.3.1.Market size and forecast, by region
  • 6.4.Military organizations
    • 6.4.1.Market size and forecast, by region

CHAPTER 7:GLOBAL MEDICAL SIMULATION, BY REGION

  • 7.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.North America: market size and forecast, by country
      • 7.2.1.1.U.S. medical simulation: market size and forecast
      • 7.2.1.1.1.U.S. medical simulation: market size and forecast, by product & service
      • 7.2.1.2.U.S. Market size and forecast, by type
      • 7.2.1.2.1.Patient simulation
      • 7.2.1.2.1.1.Market size and forecast
      • 7.2.1.2.2.Manikin-based simulation
      • 7.2.1.2.2.1.Market size and forecast
      • 7.2.1.2.3.Surgical simulation
      • 7.2.1.2.3.1.Market size and forecast
      • 7.2.1.2.4.Ultrasound simulation
      • 7.2.1.2.5.Web-based simulation
      • 7.2.1.2.5.1.Market size and forecast, by type
      • 7.2.1.2.6.Simulation training services
      • 7.2.1.2.6.1.U.S. medical simulation: market size and forecast, by fidelity
      • 7.2.1.2.7.U.S. medical simulation: market size and forecast, by end user
      • 7.2.1.3.Canada medical simulation: market size and forecast
      • 7.2.1.3.1.Canada medical simulation: market size and forecast, by product & service
      • 7.2.1.3.2.Canada medical simulation: market size and forecast, by fidelity
      • 7.2.1.3.3.Canada medical simulation: market size and forecast, by end user
      • 7.2.1.4.Mexico medical simulation: Market Size and Forecast
      • 7.2.1.4.1.Mexico medical simulation: market size and forecast, by product & service
      • 7.2.1.4.2.Mexico medical simulation: market size and forecast, by fidelity
      • 7.2.1.4.3.Mexico medical simulation: market size and forecast, by end user
    • 7.2.2.North America: market size and forecast, by product & services
    • 7.2.3.North America: market size and forecast, by fidelity
    • 7.2.4.North America: market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Europe: market size and forecast, by country
      • 7.3.1.1.Germany medical simulation: Market Size and Forecast
      • 7.3.1.1.1.Germany medical simulation: market size and forecast, by product & service
      • 7.3.1.1.2.Germany medical simulation: market size and forecast, by fidelity
      • 7.3.1.1.3.Germany medical simulation: market size and forecast, by end user
      • 7.3.1.2.France medical simulation: Market Size and Forecast
      • 7.3.1.2.1.France medical simulation: market size and forecast, by product & service
      • 7.3.1.2.2.France medical simulation: market size and forecast, by fidelity
      • 7.3.1.2.3.France medical simulation: market size and forecast, by end user
      • 7.3.1.3.UK medical simulation: market size and forecast
      • 7.3.1.3.1.UK medical simulation: market size and forecast, by product & service
      • 7.3.1.3.2.UK medical simulation: market size and forecast, by fidelity
      • 7.3.1.3.3.UK medical simulation: market size and forecast, by end user
      • 7.3.1.4.Italy medical simulation: market size and forecast
      • 7.3.1.4.1.Italy medical simulation: market size and forecast, by product & service
      • 7.3.1.4.2.Italy medical simulation: market size and forecast, by fidelity
      • 7.3.1.4.3.Italy medical simulation: market size and forecast, by end user
      • 7.3.1.5.Spain medical simulation: market size and forecast
      • 7.3.1.5.1.Spain medical simulation: market size and forecast, by product & service
      • 7.3.1.5.2.Spain medical simulation: market size and forecast, by fidelity
      • 7.3.1.5.3.Spain medical simulation: market size and forecast, by end user
      • 7.3.1.6.Rest of Europe medical simulation: market size and forecast
      • 7.3.1.6.1.Rest of Europe medical simulation: market size and forecast, by product & service
      • 7.3.1.6.2.Rest of Europe medical simulation: market size and forecast, by fidelity
      • 7.3.1.6.3.Rest of Europe medical simulation: market size and forecast, by end user
    • 7.3.2.Europe: market size and forecast, by product & service
    • 7.3.3.Europe: market size and forecast, by fidelity
    • 7.3.4.Europe: market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Asia-Pacific: market size and forecast, by country
      • 7.4.1.1.Japan medical simulation: Market Size and Forecast
      • 7.4.1.1.1.Japan medical simulation: market size and forecast, by product & service
      • 7.4.1.1.2.Japan medical simulation: market size and forecast, by fidelity
      • 7.4.1.1.3.Japan medical simulation: market size and forecast, by end user
      • 7.4.1.2.China medical simulation: market size and forecast
      • 7.4.1.2.1.China medical simulation: market size and forecast, by product & service
      • 7.4.1.2.2.China medical simulation: market size and forecast, by fidelity
      • 7.4.1.2.3.China medical simulation: market size and forecast, by end user
      • 7.4.1.3.India medical simulation: market size and forecast
      • 7.4.1.3.1.India medical simulation: market size and forecast, by product & service
      • 7.4.1.3.2.India medical simulation: market size and forecast, by fidelity
      • 7.4.1.3.3.India medical simulation: market size and forecast, by end user
      • 7.4.1.4.Australia medical simulation: market size and forecast
      • 7.4.1.4.1.Australia medical simulation: market size and forecast, by product & service
      • 7.4.1.4.2.Australia medical simulation: market size and forecast, by fidelity
      • 7.4.1.4.3.Australia medical simulation: market size and forecast, by end user
      • 7.4.1.5.Rest of Asia-Pacific medical simulation: market size and forecast
      • 7.4.1.5.1.Rest of Asia-Pacific medical simulation: market size and forecast, by product & service
      • 7.4.1.5.2.Rest of Asia-Pacific medical simulation: market size and forecast, by fidelity
      • 7.4.1.5.3.Rest of Asia-Pacific medical simulation: market size and forecast, by end user
    • 7.4.2.Asia-Pacific: market size and forecast, by product & service
    • 7.4.3.Asia-Pacific: market size and forecast, by fidelity
    • 7.4.4.Asia-Pacific: market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.LAMEA: market size and forecast, by country
      • 7.5.1.1.Brazil medical simulation: market size and forecast
      • 7.5.1.1.1.Brazil medical simulation: market size and forecast, by product & service
      • 7.5.1.1.2.Brazil medical simulation: market size and forecast, by fidelity
      • 7.5.1.1.3.Brazil medical simulation: market size and forecast, by end user
      • 7.5.1.2.South Africa medical simulation: market size and forecast
      • 7.5.1.2.1.South Africa medical simulation: market size and forecast, by product & service
      • 7.5.1.2.2.South Africa medical simulation: market size and forecast, by fidelity
      • 7.5.1.2.3.South Africa medical simulation: market size and forecast, by end user
      • 7.5.1.3.Saudi Arabia medical simulation: market size and forecast
      • 7.5.1.3.1.Saudi Arabia medical simulation: market size and forecast, by product & service
      • 7.5.1.3.2.Saudi Arabia medical simulation: market size and forecast, by fidelity
      • 7.5.1.3.3.Saudi Arabia medical simulation: market size and forecast, by end user
      • 7.5.1.4.Rest of LAMEA medical simulation: market size and forecast
      • 7.5.1.4.1.Rest of LAMEA medical simulation: market size and forecast, by product & service
      • 7.5.1.4.2.Rest of LAMEA medical simulation: market size and forecast, by fidelity
      • 7.5.1.4.3.Rest of LAMEA medical simulation: market size and forecast, by end user
    • 7.5.2.LAMEA: market size and forecast, by product & service
    • 7.5.3.LAMEA: market size and forecast, by fidelity
    • 7.5.4.LAMEA: market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.3D SYSTEMS CORPORATION (SIMBIONIX)
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
    • 8.1.6.Key strategic moves and developments
  • 8.2.CAE INC.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
    • 8.2.6.Key strategic moves and developments
  • 8.3.GAUMARD SCIENTIFIC COMPANY
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Product portfolio
    • 8.3.4.Key strategic moves and developments
  • 8.4.KYOTO KAGAKU CO. LTD.
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
  • 8.5.LAERDAL MEDICAL AS
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Key strategic moves and developments
  • 8.6.LIMBS AND THINGS LTD.
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Key strategic moves and developments
  • 8.7.MENTICE AB
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Key strategic moves and developments
  • 8.8.SIMULAB CORPORATION
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
  • 8.9.SIMULAIDS INC.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Key strategic moves and developments
  • 8.10.SURGICAL SCIENCE SWEDEN AB
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Business performance
    • 8.10.4.Key strategic moves and developments
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.